Position in AVTX
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$1,666,581
+$1,666,581 QoQ
Shares Held
90,183
Ownership
0.168%
of shares outstanding
% of Portfolio
0.27%
of 13F equity value
Holder Rank
#70
of 126 holders
Holding Since
Mar 2020
19 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in AVTX Over Time
Shares Held
Position Value (USD)
Derivatives in AVTX
reported options exposure · as of Mar 31, 2026CallValue
$5,994,395
CallShares
401,500
PutValue
$2,366,405
PutShares
158,500
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Jun 30, 2026Ikarian Capital, LLC holds $559,861,982 across 103 Biotechnology names. AVTX ranks #61 (0.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ABVX |
Abivax S.A.
|
328,635 | $43,793,900 | |
| 2 | KOD |
Kodiak Sciences Inc.
|
1,059,730 | $41,287,080 | |
| 3 | ALMS |
Alumis Inc.
|
870,548 | $24,497,220 | |
| 4 | PRAX |
Praxis Precision Medicines, Inc.
|
72,842 | $24,386,773 | |
| 5 | PCVX |
Vaxcyte, Inc.
|
388,682 | $22,594,084 | |
| 6 | CLDX |
Celldex Therapeutics, Inc.
|
478,500 | $17,804,985 | |
| 7 | RCUS |
Arcus Biosciences, Inc.
|
504,559 | $15,555,553 | |
| 8 | RLMD |
Relmada Therapeutics, Inc.
|
2,148,359 | $14,866,644 |
All Filings in AVTX
Export CSV
22 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,666,581 | 90,183 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $5,994,395 | 401,500 | Call | Sole | 2026-05-15 | |
| 2026-03-31 | $2,366,405 | 158,500 | Put | Sole | 2026-05-15 | |
| 2025-12-31 | $564,884 | 31,106 | Shares | Sole | 2026-02-18 | |
| 2025-12-31 | $1,055,096 | 58,100 | Call | Sole | 2026-02-18 | |
| 2025-09-30 | $2,030,765 | 159,777 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $176,147 | 35,300 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $1,602,000 | 200,000 | Shares | Sole | 2025-05-15 | |
| 2025-03-31 | $9,547,575 | 1,191,957 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $7,209,024 | 970,259 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $9,218,410 | 970,359 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $682,483 | 54,730 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $1,014,594 | 46,648 | Shares | Sole | 2024-05-17 | |
| 2022-03-31 | $554,096 | 764,271 | Shares | Sole | 2022-05-13 | |
| 2021-12-31 | $1,221,798 | 718,705 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $1,566,776 | 718,705 | Shares | Sole | 2021-11-15 | |
| 2021-06-30 CERC | — | 897,330 | Shares | Sole | 2021-08-18 | |
| 2021-03-31 CERC | — | 897,330 | Shares | Sole | 2021-08-18 | |
| 2020-12-31 CERC | — | 202,865 | Shares | Sole | 2021-02-12 | |
| 2020-09-30 CERC | — | 202,865 | Shares | Sole | 2020-11-16 | |
| 2020-06-30 CERC | — | 402,865 | Shares | Sole | 2020-08-14 | |
| 2020-03-31 CERC | — | 564,005 | Shares | Sole | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||